Literature DB >> 26566978

Risk of Post-TKA Acute Myocardial Infarction in Patients With a History of Myocardial Infarction or Coronary Stent.

Atul Kumar1,2, Wen-Chen Tsai3, Tai-Sheng Tan1, Li-Ting Chiu3, Pei-Tseng Kung4, Ching-Kan Lo5, Ming-Chou Ku6.   

Abstract

BACKGROUND: Acute myocardial infarction (AMI) is one of the most important perioperative complications of total knee arthroplasty (TKA). Although risk-stratification tools exist for the prediction of cardiac complications including AMI after noncardiac surgery, such stratification does not differentiate the patients with a coronary stent alone, AMI without a stent, or AMI with a stent. The risk of postoperative AMI in these patient groups may vary. Several studies have recommended suitable times for noncardiac surgery in patients with a coronary stent; however, they do not differentiate between the patients with AMI and no AMI. The suitable time of noncardiac surgery for patients with AMI and stent may vary from those with a stent alone. Moreover, a study to evaluate the risk of AMI within 1 year in an Asian population with a history of AMI or coronary stent who underwent TKA has not been reported. QUESTIONS/PURPOSES: (1) What are the risks of AMI within 1 year of TKA in patients who have had a stent alone, AMI without a stent, or AMI with a stent as compared with patients without an AMI/stent? (2) For patients with AMI/stent placement, when can TKA be performed where the risk of subsequent AMI normalizes? (3) What comorbidities are associated with post-TKA AMI? (4) Is the risk of AMI within 1 year after surgery in patients undergoing TKA without a history of AMI/stent higher than that in patients with no surgery?
METHODS: This study is a retrospective study of the medical claim records of 128,216 patients who underwent TKA between 1997 and 2010 in Taiwan. The records were retrieved from the research database of the Bureau of National Health Insurance in Taiwan, which maintains the records of 99.68% of the Taiwan population. The patients who had a history of AMI or coronary stent placement within the year before TKA were compared with the patients who had not experienced AMI or stent placement before TKA. The control subjects were matched according to sex, age, Charlson score, and year of surgery. There were 2413 patients in each group. The patients with a history of AMI or stent placement and the timing of TKA after coronary event were further stratified as with a coronary stent alone, AMI without a stent, and AMI with a stent. The effects of the comorbidities of renal failure, diabetes, liver failure, and hypertension were also analyzed individually. The risk of AMI within 1 year after TKA was investigated using bivariate analysis and the Cox proportional hazard model. To compare the risk of AMI within 1 year of surgery in the patients with a history of TKA and no AMI/stent with the population without a history of surgery, a similar bivariate analysis and the Cox proportional hazard model were applied to their matched case and control groups, each containing 110,980 patients.
RESULTS: In the adjusted model, using no AMI/stent before TKA as a reference, patients having undergone AMI + stent had the highest risk (hazard ratio [HR], 5.23; 95% confidence interval [CI], 1.81-15.14; p = 0.002), AMI alone without a stent had less risk (HR, 4.88; 95% CI, 1.49-16.01; p = 0.009), and stent alone with AMI had the lowest risk (HR, 3.16; 95% CI, 1.29-7.71; p = 0.012). In all patients, risk of AMI after TKA was not different than reference values after 1 year of initial AMI or stent (stent: HR, 1.67; 95% CI, 0.71-3.94; p = 0.239; AMI: HR, 1.88; 95% CI, 0.42-8.49; p = 0.412; AMI + stent: HR, 1.91; 95% CI, 0.53-6.89; p = 0.321). The risk of post-TKA AMI was elevated within 1 year of the previous episode of AMI/stent (0-180 days: HR, 8.42; 95% CI, 3.03-23.41; p < 0.001; 181-365 days: HR, 7.52; 95% CI, 2.47-22.88; p < 0.001). Only chronic renal failure under hemodialysis was associated with increased risk of AMI within 1 year of TKA (adjusted HR, 4.34; 95% CI, 1.22-15.43; p = 0.023). Patients undergoing TKA with no history of AMI/stent had a lower risk of AMI within 1 year of TKA compared with the patients with no history of surgery (adjusted HR, 0.92; 95% CI, 0.86-0.99; p = 0.016).
CONCLUSIONS: This study found the risk of post-TKA AMI remains high within 1 year in patients with a history of AMI/stent. It is recommended that an elective TKA should be performed at least 1 year after an episode of AMI or stent placement. Stents do not provide protection against post-TKA AMI within 6 months of the AMI and patients with AMI + stent have a higher risk of AMI than those with only AMI. Patients of AMI/stent on hemodialysis have a very high risk of post-TKA AMI. However, the risk of AMI is lower in post-TKA patients compared with those with no TKA. LEVEL OF EVIDENCE: Level III, prognostic study.

Entities:  

Mesh:

Year:  2015        PMID: 26566978      PMCID: PMC4709274          DOI: 10.1007/s11999-015-4616-z

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  23 in total

Review 1.  Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk.

Authors:  P J Devereaux; Lee Goldman; Deborah J Cook; Ken Gilbert; Kate Leslie; Gordon H Guyatt
Journal:  CMAJ       Date:  2005-09-13       Impact factor: 8.262

2.  Risk of elective major noncardiac surgery after coronary stent insertion: a population-based study.

Authors:  Duminda N Wijeysundera; Harindra C Wijeysundera; Lingsong Yun; Marcin Wąsowicz; W Scott Beattie; James L Velianou; Dennis T Ko
Journal:  Circulation       Date:  2012-08-14       Impact factor: 29.690

3.  Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients.

Authors:  G Ocak; K J van Stralen; F R Rosendaal; M Verduijn; P Ravani; R Palsson; T Leivestad; A J Hoitsma; M Ferrer-Alamar; P Finne; J De Meester; C Wanner; F W Dekker; K J Jager
Journal:  J Thromb Haemost       Date:  2012-12       Impact factor: 5.824

4.  Coronary revascularization after myocardial infarction can reduce risks of noncardiac surgery.

Authors:  Masha Livhits; Melinda Maggard Gibbons; Christian de Virgilio; Jessica B O'Connell; Michael J Leonardi; Clifford Y Ko; David S Zingmond
Journal:  J Am Coll Surg       Date:  2011-03-26       Impact factor: 6.113

5.  Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty.

Authors:  Carlos B Mantilla; Terese T Horlocker; Darrell R Schroeder; Daniel J Berry; David L Brown
Journal:  Anesthesiology       Date:  2002-05       Impact factor: 7.892

6.  Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE).

Authors:  Keith A A Fox; Omar H Dabbous; Robert J Goldberg; Karen S Pieper; Kim A Eagle; Frans Van de Werf; Alvaro Avezum; Shaun G Goodman; Marcus D Flather; Frederick A Anderson; Christopher B Granger
Journal:  BMJ       Date:  2006-10-10

7.  Risk for perioperative myocardial infarction and mortality in patients undergoing hip or knee arthroplasty: the role of anemia.

Authors:  Carlos B Mantilla; C Thomas Wass; Karissa A Goodrich; Cassie J Johanns; Michelle L Kool; Xun Zhu; Jose A Corredor; David O Warner; Michael J Joyner; Daniel J Berry; Darrell R Schroeder; Juraj Sprung
Journal:  Transfusion       Date:  2011-01       Impact factor: 3.157

8.  Catastrophic outcomes of noncardiac surgery soon after coronary stenting.

Authors:  G L Kałuza; J Joseph; J R Lee; M E Raizner; A E Raizner
Journal:  J Am Coll Cardiol       Date:  2000-04       Impact factor: 24.094

9.  Risks of noncardiac surgery after coronary stenting.

Authors:  Proddutur R Reddy; Paul T Vaitkus
Journal:  Am J Cardiol       Date:  2005-03-15       Impact factor: 2.778

10.  Validation of acute myocardial infarction cases in the national health insurance research database in taiwan.

Authors:  Ching-Lan Cheng; Cheng-Han Lee; Po-Sheng Chen; Yi-Heng Li; Swu-Jane Lin; Yea-Huei Kao Yang
Journal:  J Epidemiol       Date:  2014-08-30       Impact factor: 3.211

View more
  4 in total

1.  What Is the Timing of General Health Adverse Events That Occur After Total Joint Arthroplasty?

Authors:  Daniel D Bohl; Nathaniel T Ondeck; Bryce A Basques; Brett R Levine; Jonathan N Grauer
Journal:  Clin Orthop Relat Res       Date:  2017-12       Impact factor: 4.176

2.  Perioperative acute myocardial infarction in patients after non-cardiac surgery in China: Characteristics and risk factors.

Authors:  Xiaoxin Zhou; Lingke Chen; Zhongxue Su; Yue Li; Mengyun Tu; Jie Xiao; Zhiying Pan; Diansan Su
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

3.  The Risk of Bleeding and Adverse Events with Clopidogrel in Elective Hip and Knee Arthroplasty Patients.

Authors:  Cheng-Ta Wu; Tzu-Hsien Lien; I-Ling Chen; Jun-Wen Wang; Jih-Yang Ko; Mel S Lee
Journal:  J Clin Med       Date:  2022-03-22       Impact factor: 4.241

4.  Outcome and cost analysis of primary total knee arthroplasty in end-stage renal disease patients: A nationwide population-based study.

Authors:  Sheng-Hsun Lee; Yu-Chih Lin; Chee-Jen Chang; Chih-Yun Fan Chiang; Szu-Yuan Chen; Yu-Han Chang; Pang-Hsin Hsieh; Chih-Hsiang Chang
Journal:  Biomed J       Date:  2020-05-07       Impact factor: 4.910

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.